13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2018-01-26 Event — SEC 0000947871-18-000055 →

ORBIMED ADVISORS LLC Nabriva Therapeutics plc

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
31 filings by this filer
30 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other 13D/G Filings on Nabriva Therapeutics plc

FiledFormFilerStakeShares
2018-01-26 SC ORBIMED ADVISORS LLC view →

Other Filings by ORBIMED ADVISORS LLC

FiledFormIssuerStakeShares
2026-04-10 SCHEDULE 13D/A Adicet Bio, Inc. ACET 8.80% 844,787 view →
2018-07-02 SC Aerpio Pharmaceuticals, Inc. WHWK view →
2018-05-02 SC PIERIS PHARMACEUTICALS, INC. PVLA view →
2018-04-12 SC SYNLOGIC, INC. SYBX view →
2018-03-14 SC Corvus Pharmaceuticals, Inc. CRVS view →
2018-03-06 SC ViewRay, Inc. view →
2018-02-16 SC Intellia Therapeutics, Inc. NTLA view →
2018-02-15 SC Xtant Medical Holdings, Inc. XTNT view →
2018-02-07 SC RHYTHM PHARMACEUTICALS, INC. RYTM view →
2018-01-29 SC Ascendis Pharma A/S ASND view →
2018-01-29 SC Intellia Therapeutics, Inc. NTLA view →
2018-01-26 SC Arsanis, Inc. XFOR view →
2018-01-26 SC SteadyMed Ltd. view →
2018-01-26 SC scPharmaceuticals Inc. view →
2018-01-26 SC ALPINE IMMUNE SCIENCES, INC. view →
2018-01-26 SC PIERIS PHARMACEUTICALS, INC. PVLA view →
2018-01-26 SC Verona Pharma plc view →
2018-01-26 SC Sorrento Tech, Inc. view →
2018-01-26 SC ALPINE IMMUNE SCIENCES, INC. view →
2018-01-26 SC ViewRay, Inc. view →
Showing 20 of 30

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →